<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Disseminated form of the Kaposi sarcoma in HIV-negative patient associated with Hodgkin's lymphoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Disseminated form of the Kaposi sarcoma in HIV-negative patient associated with Hodgkin's lymphoma." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aaa/7507874/e92a5a57ff72/omaa069f1.jpg"/> </div> <div class="text-side"> <h1>Disseminated form of the Kaposi sarcoma in HIV-negative patient associated with Hodgkin's lymphoma.</h1> <p>Diagnosis of the nodular lymphocyte-predominant Hodgkin lymphoma. (A) The nodular architecture of NLPHL (H&amp;E, original magnification 100x). (B) Lymphocyte-predominant (LP) cells in the NLPHL with typical popcorn morphology indicated by the arrows (H&amp;E, original magnification 400x). (C) Extensive background of CD4+ T-lymphocytes (original magnification 400x). Immunohistochemical (IHC) characterization of LP cells: (D) positive membranous and cytoplasmic staining of CD20 (original magnification 400x), (E) weak positive cytoplasmic staining of CD79a (original magnification 400X), (F) positive membrane staining of CD45 (original magnification 400x) and (G) weak positive staining of CD30 (original magnification 400x). (H) NLPHL with positive LMP1 expression noted in the LP and T cells (original magnification 400x).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32995025/" target="_blank">32995025</a></p><p>Type: Premalignant/Malignant, Category: Vascular</p>
</div> </div></div></body></html>